How much do paid clinical trials in York pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in York?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in York safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How often do new paid studies open in York?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of York.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in York typically complete one or two studies per year.

Paid Clinical Trials York, PA — 459 Studies Recruiting (Jul 2026)

Use of Nicotine Pouches Among Daily Smokers

Tobacco Dependence N/A Interventional 375 participants sought

Penn State College of Medicine — Hershey, Pennsylvania (22.6 mi) · Sponsor: Milton S. Hershey Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT06043362)

Transitional Care Program for Fluid Overload in Cirrhosis

Cirrhosis, Liver N/A Interventional 20 participants sought

Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Milton S. Hershey Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT06174272)

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought

The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Steba Biotech S.A.

See eligibility & contact on ClinicalTrials.gov (NCT04620239)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought

UPMC Memorial — York, Pennsylvania (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Primary Central Nervous System Lymphoma Phase 2 Interventional 28 participants sought

Pennsylvania State University — Hershey, Pennsylvania (22.6 mi) · Sponsor: Providence Health & Services

See eligibility & contact on ClinicalTrials.gov (NCT06175000)

Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens

Hematologic Tests N/A Interventional 425 participants sought

Penn State Health Milton S. Hershey Medical Center (Hershey) — Hershey, Pennsylvania (22.6 mi) · Sponsor: Abbott Point of Care

See eligibility & contact on ClinicalTrials.gov (NCT07287631)

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary Angioedema, HAE Phase 3 Interventional 90 participants sought

ADARx Clinical Site — Hershey, Pennsylvania (22.6 mi) · Sponsor: ADARx Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06960213)

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Infant, Intubation Complication N/A Interventional 3,000 participants sought

Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Children's Hospital of Philadelphia

See eligibility & contact on ClinicalTrials.gov (NCT05838690)

Stroke Thrombectomy and Aneurysm Registry

Stroke, Thromboses, Intracranial N/A Observational 40,000 participants sought

WellSpan York Hospital — York, Pennsylvania (0.3 mi) · Sponsor: Medical University of South Carolina

See eligibility & contact on ClinicalTrials.gov (NCT04994756)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

The CONFORM Pivotal Trial

Atrial Fibrillation, Stroke N/A Interventional 1,600 participants sought

UPMC Harrisburg — Mechanicsburg, Pennsylvania (22.6 mi) · Sponsor: Conformal Medical, Inc

See eligibility & contact on ClinicalTrials.gov (NCT05147792)

Impact of Parental Emotion Regulation on the Treatment of ADHD

ADHD N/A Interventional 65 participants sought

Penn State Health Dept of Psychiatry — Hershey, Pennsylvania (22.6 mi) · Sponsor: Milton S. Hershey Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT05299814)

The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study

Mitral Valve Insufficiency N/A Interventional 30 participants sought

UPMC Heart & Vascular Institute — Harrisburg, Pennsylvania (22.8 mi) · Sponsor: Half Moon Medical

See eligibility & contact on ClinicalTrials.gov (NCT04343313)

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Amblyopia Phase 3 Interventional 252 participants sought

Conestoga Eye — Lancaster, Pennsylvania (23.1 mi) · Sponsor: Jaeb Center for Health Research

See eligibility & contact on ClinicalTrials.gov (NCT06524882)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought

UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion — Mechanicsburg, Pennsylvania (22.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07198074)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought

Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Atopic Dermatitis Phase 2 Interventional 120 participants sought

Best Skin Research LLC — Camp Hill, Pennsylvania (21.4 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT07223697)

Optimizing Pain Treatment in Children On Mechanical Ventilation

Mechanical Ventilation, Pediatric Acute Respiratory Failure Phase 3 Interventional 644 participants sought

Penn State Health/Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Weill Medical College of Cornell University

See eligibility & contact on ClinicalTrials.gov (NCT06994442)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought

Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07225946)

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 150 participants sought

Cancer Care Associates Of York /ID# 270971 — York, Pennsylvania (0.3 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT06568939)

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

Prostate Cancer, Diagnosis N/A Interventional 1,306 participants sought

Pennsylvania State University — Hershey, Pennsylvania (22.6 mi) · Sponsor: Albany Medical College

See eligibility & contact on ClinicalTrials.gov (NCT06517901)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought

Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT01810913)

iLookOut Micro-learning to Improve Knowledge Retention

Knowledge, Attitudes N/A Interventional 12,000 participants sought

Penn State College of Medicine — Hershey, Pennsylvania (22.6 mi) · Sponsor: Milton S. Hershey Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT06273618)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought

Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04251052)

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Phase 3 Interventional 250 participants sought

Keystone Urology Specialists — Lancaster, Pennsylvania (23.1 mi) · Sponsor: Ferring Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT06545955)

Paid Clinical Trials in York, PA

Studies recruiting near York right now

Use of Nicotine Pouches Among Daily Smokers

Transitional Care Program for Fluid Overload in Cirrhosis

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Stroke Thrombectomy and Aneurysm Registry

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

The CONFORM Pivotal Trial

Impact of Parental Emotion Regulation on the Treatment of ADHD

The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Optimizing Pain Treatment in Children On Mechanical Ventilation

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

iLookOut Micro-learning to Improve Knowledge Retention

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Top-rated research centers in York

Information Collection Enterprises

Presa Clinical Research, LLC.

Capital Area Research LLC

Clinicaltrialmd.com

Cancer Care Associates of York

Kingston Court Skilled Nursing and Rehabilitation Center

Select Physical Therapy - East York

Milan Laser Hair Removal

Innovo Detox

Clinical trials in York: what's recruiting

How to enroll in a paid study in York

Frequently asked questions

Paid clinical trials near York

More of PA

New paid studies open every week